The company's immunologic scoring tests use a proprietary set of immune biomarkers and advanced image analysis technologies to precisely measure the immune reaction in and around the tumor. This enables clinicians to determine the degree of severity of the patient's disease and predict response to treatment. Veracyte is a global diagnostics company that provides insights, expertise, and capabilities to empower biopharmaceutical partners to confidently advance every step of their oncology drug development programs.